electroCore (ECOR) vs Microbot Medical (MBOT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
electroCore (ECOR) has outperformed Microbot Medical (MBOT) over the past year, gaining 84.7% versus a loss of 67.5%. Over five years, ECOR leads with a -36.4% price change compared with -85.1% for MBOT. electroCore is the larger company by market cap ($87.1 million vs $71.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ECOR | MBOT |
|---|---|---|
| Share price | $9.66 | $1.07 |
| Market cap | $87.09M | $71.87M |
| 1-day change | +1.58% | 0.00% |
| YTD return | +112.04% | -46.50% |
| 1-year return | +84.66% | -67.48% |
| 5-year return | -36.41% | -85.08% |
| EPS (TTM) | $-1.65 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.70 | $3.17 |
| 52-week low | $4.41 | $1.05 |
| Distance from 52-week high | -23.94% | -66.25% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +98.45% | +491.59% |
| Average volume | 80.51K | 649.10K |
| Shares outstanding | 9.02M | 67.16M |
| Employees | 83 | 43 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ECOR has outperformed MBOT by 152.1 percentage points over the past year.
About electroCore
ECOR stock →electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Health Care · Medical/Dental Instruments · 43 employees
ECOR vs MBOT FAQ
Which is bigger, electroCore or Microbot Medical?
electroCore (ECOR) is larger, with a market capitalization of $87.09M compared with $71.87M for Microbot Medical (MBOT).
Which stock has performed better over the past year, ECOR or MBOT?
ECOR returned +84.66% over the past 12 months, compared with -67.48% for MBOT (price return, excluding dividends). Past performance does not predict future results.
Are electroCore and Microbot Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for electroCore and Medical/Dental Instruments for Microbot Medical.